Sivers Semiconductors Courts US Investors While Shareholders Weigh Dilution Risk

Sivers Semiconductors plans a Silicon Valley investor relations chief as shares trade at EUR 2.41, with an October 22 vote on dilution ahead.

Sivers Semiconductors is sharpening its focus on American capital markets, unveiling plans this week to install a dedicated investor relations chief in California's Silicon Valley. The newly created executive role will report straight to the CEO, a structure the Swedish chipmaker says will tighten the feedback loop between its operating business and the financial community.

The appointment is still to be filled, but the intent is clear: deepen dialogue with institutional backers across the United States and beyond. Word of the recruitment drive landed on Monday, and by midweek the stock was changing hands at EUR 2.41, up 2.8% on the day — a gain that stood out against a broadly weaker semiconductor tape.

A rough stretch for chip names

That broader weakness has been hard to miss. Renewed anxiety over artificial intelligence spending, compounded by reports that China's CXMT is developing new server memory chips, has weighed on chip equities on both sides of the Atlantic. The news stoked fears of sharper competition and raised questions about the durability of AI-related outlays. Sivers shares have not been immune to the wider malaise: at current levels the stock sits roughly 77% below its 52-week high of EUR 10.23, touched in early June.

No company-specific catalyst has been identified for Wednesday's advance, leaving the move to stand largely on its own.

US market access takes shape

The Silicon Valley hire is only one plank of a broader American push. On October 5, Citibank registered 50,000,000 American Depositary Shares, each representing three ordinary Sivers shares — a mechanism that smooths the path for US market participants to trade the name. Add to that the expansion of the company's manufacturing site in Glasgow, announced about a month ago, and a picture emerges of a business extending both its industrial and capital-markets reach. Should the ADR program succeed in drawing fresh institutional interest, it could open a new source of demand for the equity.

The dilution question looms large

Before any of that can be judged, shareholders face a more immediate test. An extraordinary general meeting, convened roughly two weeks ago, is set for October 22, 2026, and the agenda carries consequential items. Chief among them is a proposed employee options program covering up to 7,280,000 options — equivalent to dilution of about 2.0%. Combined with existing plans, the company puts the maximum total dilution at approximately 6.1%.

A second resolution would hand the audit mandate to EY, replacing Deloitte. The outcome of both votes will shape how much room management has to press ahead with its US ambitions.

Insider exit and short interest draw scrutiny

Sentiment around the shareholder register has hardly been calm. Thomas Duffy, the company's former chairman, disposed of his entire holding — 840,000 shares — in transactions carried out between June 26 and September 28, according to data from the research service Holdings. A full exit by a onetime senior figure tends to read as a cautious signal, and it lands alongside a notable short-selling presence. Citadel Securities disclosed a net short position of 0.54% of capital on October 9, a date on which total published short positions in the stock amounted to 5.53%.

Taken together — the dilution overhang, the insider sale, and the short interest — the backdrop explains why many market participants remain guarded even as the stock firms.

What the coming weeks will decide

For now, the EUR 2.41 level is the line traders are watching. Hold it, and the constructive case for a US build-out stays intact. Lose it — whether through rejection of the options program or another leg down in the semiconductor sector — and the broader downtrend could reassert itself. The October 22 vote will be the clearest signal yet of whether management heads into its American campaign with shareholder backing or without it.